Vinpai

Vinpai FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Vinpai (ALVIN.PA) as of Oct 27, 2026 is 6.67 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 0.02 % — a change of 41,747.56% (higher).

FCF Conversion

6.67 %

YoY

41,747.56%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Vinpai is 2025 6.67 % . FCF Conversion Rate (FCF/EBITDA) of Vinpai was 2024 0.02 % . It decreases by 41,747.56% higher compared to the previous year.

The Vinpai FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2021
97.92 EUR
Jan 1, 2022
0.02 EUR
Jan 1, 2023
0.02 EUR
Jan 1, 2025
6.67 EUR
The Vinpai FCF Conversion history
YEARFCF ConversionYoY
6.67 %+41,747.56%
0.02 %-26.15%
0.02 %-99.98%
97.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vinpai Stock analysis

What does Vinpai do? Vinpai SA generates revenue through the design, manufacture, and marketing of algae- and plant-based functional ingredients for the food and cosmetics industries. The company offers standard and tailor-made products including alternative cheeses, dressing sauces, dairy alternative products, biscuits, cakes, and flavours across its four business segments: food industry, cosmetics, food supplementation, and medical device. VINPAI Cosmetics develops algae-mineral solutions for peel-off masks, actives, and ingredients ranges, as well as medical device solutions from dental to patch and moulding. The company serves customers in more than 40 countries worldwide, with its products primarily targeting food manufacturers, cosmetics brands, and medical device companies seeking sustainable, plant-based alternatives. Vinpai SA's product portfolio includes alternative cheeses, dressing sauces, dairy alternatives, biscuits, cakes, and flavours for the food industry segment. For cosmetics, the company provides algae-mineral solutions for peel-off masks, actives, and ingredients. The medical device segment focuses on dental, patch, and moulding solutions. Food supplementation involves plant-based functional ingredients tailored for dietary needs. The company's global presence in over 40 countries supports its sales to food manufacturers, cosmetics brands, and medical device companies. The company's revenue streams are derived from the sale of its standard and custom products to food manufacturers, cosmetics brands, and medical device companies. VINPAI Cosmetics' algae-mineral solutions for peel-off masks and actives are sold to cosmetics brands, while medical device solutions for dental, patch, and moulding applications are sold to medical device companies. Food supplementation ingredients target dietary supplement manufacturers, and dairy alternatives and plant-based flavours are sold to food producers across multiple industries. Vinpai is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vinpai stock

FCF Conversion Rate (FCF/EBITDA) of Vinpai is 6.67 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Vinpai changed from 0.02 % to 6.67 %, representing a 41,747.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Vinpai since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Vinpai with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Vinpai

All Key Metrics — Vinpai